Robert B. Hance, Senior Vice President at ABBOTT LABORATORIES (ABT), sold 14,800 shares at $45.27 ($670K) on 2011-01-31, disclosed to the SEC on 2011-02-01.
Scheduled sale ($670k) by Senior Vice President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $45.27 | 100 | $5K | 0.7% |
| 2 | $45.27 | 6,300 | $285K | 42.6% |
| 3 | $45.27 | 8,400 | $380K | 56.8% |
| Total | $45.27 avg | 14,800 | $670K | 100% |
| Filing → |
| ABT | SELL | 2012-03-02 | $4.6M | — | Filing → |
| ABT | SELL | 2011-12-16 | $4.2M | — | Filing → |
| ABT | SELL | 2011-03-02 | $75K | — | Filing → |